冰山冷熱(000530.SZ):擬以1.45億元受讓松下製冷100%的股權
格隆匯5月5日丨冰山冷熱(000530.SZ)公佈,松下製冷(大連)有限公司(“松下製冷”)由松下電器(中國)有限公司(“松下中國”)和三洋電機株式會社(“三洋電機”)共同出資設立。松下製冷註冊資本為34.5億日元,松下中國持有松下製冷40%股權,三洋電機持有松下製冷60%股權。
為強化業務協同,為客户節能環保提供更加優化的解決方案,公司於2023年5月4日與松下中國、三洋電機簽署《附條件生效的股權轉讓協議》,受讓松下中國所持松下製冷40%股權、三洋電機所持松下製冷60%股權。根據評估結果,確定松下製冷100%股權的受讓價格為14528.55萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.